瑞银:维持evolent health(EVH.US)评级,由买入调整至买入评级,目标价由27.00美元调整至14.00美元。Evolent Health(EVH.US)公司简介:Evolent Health Inc从事医疗保健服务和支付。该公司支持卫生系统和医生组织转向基于价值的护理和人口健康管理。它提供肿瘤学、心脏病学、肌肉骨骼市场的专业护理管理服务和护理总成本管理,以及一个用于健康计划管理和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.